Research utilizing experimental autoimmune encephalomyelitis (EAE), a well-established animal model for MS, indicates that OPN deficiency leads to a significant reduction in disease severity, thereby underscoring the role of OPN in driving MS progression [119]. This evidence concerns the gene SPP1 and myeloid sarcoma.